Published on October 10, 2009
Contact: Julie Monzo
Orlando Pathologist Named Distinguished Service Award Recipient by the College of American Pathologists
Northfield, IL.—Steven I. Gutman, MD, FCAP, of Orlando, Fla., was awarded the College of American Pathologists (CAP) Distinguished Service Award at a ceremony held on October10, 2009, in Washington DC at CAP ’09 – THE Pathologists’ Meeting™.
The Distinguished Service Award recognizes outstanding contributions to both the practice of pathology and to the College of American Pathologists. Dr. Gutman was presented with the CAP Distinguished Service Award for his contributions in promoting and protecting public health through clear and consistent regulation of in-vitro diagnostic devices (IVDs) as Director of the Office of In-Vitro Diagnostic Device Evaluation and Safety (OIVD)-Center for Devices and Radiological Health at the Food and Drug Administration (FDA).
“I am deeply honored to receive the CAP Distinguished Service Award,” said Dr. Gutman. “I have greatly enjoyed being able to contribute to the advancement of patient safety and of pathologists’ involvement in protecting public health.”
In addition to his work with CAP, Dr. Gutman has served as a member of the Clinical Laboratory Improvement Amendments Committee; the Secretary’s Advisory Committee on Genomics, Health and Society; and the US Technical Advisory Group for the ISO TC 212 committee for international laboratory standards. At FDA he helped found and was the first director of the Office of In Vitro Diagnostics, a regulatory unit responsible for all oversight functions for in vitro diagnostics including premarket review, compliance activities and patient safety surveillance.
Recently Dr. Gutman has been actively involved in a number of initiatives to promote drug-diagnostic co-development and personalized health care. He has worked with the NIH Biorepository Research Network, the Program on Assessment of Clinical Cancer Tests, and was the lead co-chair of the Bioassay Validation Committee under the Cancer Biomarker Consoritum initiated bythe American Association of Cancer Research.
Dr. Gutman currently serves as professor of Pathology at the University of Central Florida College of Medicine in Orlando, Fla. In this role, he is working to co-develop the pathology curriculum and serves as a founding member for this new medical school. Dr. Gutman graduated with a BS magna cum from the Ohio State University in Columbus, Ohio. He completed his MD at Cornell University Medical College in New York and obtained an MBA with distinction at SUNY at Buffalo.
He completed residency training in anatomic pathology at Cornell University Medical College and in clinical pathology residency at the Mayo Clinic in Rochester, Minn.
The College of American Pathologists (CAP) is a medical society serving more than 17,000 physician members and the laboratory community throughout the world. It is the world’s largest association composed exclusively of board certified pathologists and is widely considered the leader in laboratory quality assurance. The College is an advocate for high-quality and cost-effective patient care.